Skip to main content
. 2021 Oct 15;11:710163. doi: 10.3389/fonc.2021.710163

Figure 1.

Figure 1

Long-term morbidities following pediatric ALL treatment. The commonly reported long-term morbidities for pediatric ALL survivors and their estimated prevalence as reported from large studies like the CCSS. EOT, end of therapy.